Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multilevel botulinum toxin A plus physiotherapy in ambulatory children with cerebral palsy
NL-OMON21315Active, not recruiting
- Start
- Feb 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in cerebral palsy (CP) (2 arms). Primary endpoints: Gross Motor Function Measure and Energy cost of walking. Started Feb 2001; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NL-OMON21315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21315.